News Image

Dyne Therapeutics Announces Chief Business Officer and Chief Scientific Officer Appointments

Provided By GlobeNewswire

Last update: Apr 15, 2025

- Vikram Ranade, PhD, appointed as chief business officer -

- Ranjan Batra, PhD, appointed as chief scientific officer -

- Oxana Beskrovnaya, PhD, transitioning to chief innovation officer -

Read more at globenewswire.com

DYNE THERAPEUTICS INC

NASDAQ:DYN (12/19/2025, 8:00:01 PM)

After market: 19.85 0 (0%)

19.85

+1.3 (+7.01%)



Find more stocks in the Stock Screener

Follow ChartMill for more